InVivoMAb anti-mouse IL-10
BE0049
ApplicationsNeutralisation/Blocking
Product group Antibodies
ReactivityMouse
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse IL-10
- Delivery Days Customer7
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDJES5-2A5
- Concentration4-11 mg/ml
- Estimated Purity≥95% , Determined by SDS-PAGE
- HostRat
- IsotypeIgG1
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC41116161
References
- Transforming Growth Factor-beta and Interleukin-10 Synergistically Regulate Humoral Immunity via Modulating Metabolic Signals. Komai T et al., 2018, Front ImmunolRead this paper
- Expanding antigen-specific regulatory networks to treat autoimmunity. Clemente-Casares X et al., 2016 Feb 25, NatureRead this paper
- IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age. Tsukamoto H et al., 2015 Apr 7, Nat CommunRead this paper
- Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression. Martinson HA et al., 2015 Apr 15, Int J CancerRead this paper
- The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells. Vegran F et al., 2014 Aug, Nat ImmunolRead this paper
- Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. de Almeida PE et al., 2014 May 30, Nat CommunRead this paper
- Myeloid PTEN deficiency protects livers from ischemia reperfusion injury by facilitating M2 macrophage differentiation. Yue S et al., 2014 Jun 1, J ImmunolRead this paper
- TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice. Tai N et al., 2013 Sep 15, J ImmunolRead this paper
- B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms. Podojil JR et al., 2013 Aug, J AutoimmunRead this paper
- Modulation of dendritic cell differentiation in the bone marrow mediates sustained immunosuppression after polymicrobial sepsis. Pastille E et al., 2011 Jan 15, J ImmunolRead this paper
